Javier
Diez Domingo
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (6)
2024
-
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
Journal of Infectious Diseases, Vol. 229, pp. S100-S111
2020
-
Economic evaluation of meningococcal vaccines: considerations for the future
European Journal of Health Economics, Vol. 21, Núm. 2, pp. 297-309
2013
-
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain
Vaccine, Vol. 31, Núm. 46, pp. 5486-5494
-
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Vaccine, Vol. 31, Núm. 42, pp. 4765-4774
2012
-
13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: Immunogenicity and safety
Pediatric Infectious Disease Journal, Vol. 31, Núm. 4, pp. 392-399
2011
-
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine
Vaccine, Vol. 29, Núm. 35, pp. 6042-6048